JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M200421200 on March 8, 2002

J. Biol. Chem., Vol. 277, Issue 21, 18454-18458, May 24, 2002
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/21/18454    most recent
M200421200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ramadan, K.
Right arrow Articles by Hübscher, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ramadan, K.
Right arrow Articles by Hübscher, U.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

DNA Polymerase lambda  from Calf Thymus Preferentially Replicates Damaged DNA*

Kristijan RamadanDagger , Igor V. ShevelevDagger §, Giovanni Maga, and Ulrich HübscherDagger ||

From the Dagger  Institute of Veterinary Biochemistry and Molecular Biology, University of Zürich-Irchel, Winterthurerstrasse 190, CH-8057, Zürich, Switzerland, § Department of Molecular and Radiation Biophysics, Petersburg Nuclear Physics Institute, Leningrad district, Gatchina, 188300, Russia, and  Istituto di Genetica Molecolare, Consislio Nationale dell Ricerche, Via Abbiategrasso 207, I-27100, Pavia, Italy

Received for publication, January 15, 2002, and in revised form, March 5, 2002

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
REFERENCES

A new gene (POLL), has been identified encoding the novel DNA polymerase lambda  and mapped to mouse chromosome 19 and at human chromosome 10. DNA polymerase lambda  contains all the critical residues involved in DNA binding, nucleotide binding, nucleotide selection, and catalysis of DNA polymerization and has been assigned to family X based on sequence homology with polymerase beta , lambda , µ, and terminal deoxynucleotidyltransferase. Here we describe a purification of DNA polymerase lambda  from calf thymus that preferentially can replicate damaged DNA. By testing polymerase activity on non-damaged and damaged DNA, DNA polymerase lambda  was purified trough five chromatographic steps to near homogeneity and identified as a 67-kDa polypeptide that cross-reacted with monoclonal antibodies against DNA polymerase beta  and polyclonal antibodies against DNA polymerase lambda . DNA polymerase lambda  had no detectable nuclease activities and, in contrast to DNA polymerase beta , was aphidicolin-sensitive. DNA polymerase lambda  was a 6-fold more accurate enzyme in an M13mp2 forward mutation assay and 5-fold more accurate in an M13mp2T90 reversion system than human recombinant DNA polymerase beta . The biochemical properties of the calf thymus DNA polymerase lambda , described here for the first time, are discussed in relationship to the proposed role for this DNA polymerase in vivo.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
REFERENCES

Eukaryotic cells contain several DNA polymerases (pol)1 classified as classical pols (alpha , beta , gamma , delta , and epsilon ) and novel pols (zeta , eta , phi , kappa , lambda , theta , iota , and µ) (1). Novel pols have so far never been purified directly from mammalian tissues.

Recombinant murine pol lambda  (67 kDa) is a protein composed of 573 amino acids and is highly similar to the members of the pol family X (2) comprising enzymes involved in the DNA repair processes, whose main member is pol beta . The first 239 amino acids of the N-terminal part of pol lambda  with the exception of the nuclear localization signal have no counterpart in pol beta . This N-terminal part of pol lambda  has similarity to yeast pol IV and contains a BRCA1 C-terminal (BRCT) domain (2). The BRCT domain is present in several proteins involved in DNA repair and cell cycle checkpoint control (3, 4). Recently, it has been shown that the BRCT domain is involved in protein/protein interactions (4). The remaining part of pol lambda  is composed of the catalytic core, which is similar to pol beta  (8-kDa DNA deoxyribophosphodiesterase domain and 32-kDa finger, palm, and thumb-polymerization domain) and has 32% amino acid identity to pol beta  (2).

Pol lambda  contains 5'-deoxyribose phosphate lyase activity, but no apurinic lyase activity (5), and can substitute pol beta  in in vitro base excision repair (BER), suggesting that pol lambda  participates in BER. Pol beta  is the main pol involved in the BER of lesions generated by monofunctional alkylating agents in eukaryotic nuclear DNA, and pol lambda  was proposed to be involved in the other types of BER (5). However, understanding the possible physiological roles of this enigmatic pol would require a complete characterization of the biochemical properties of the endogenous enzyme. In this study, we describe, for the first time, the isolation of endogenous pol lambda  from a mammalian tissue. Remarkably, this activity was isolated by an activity assay that uses damaged DNA as a template, suggesting a possible role of pol lambda  in DNA repair and translesion synthesis.

    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
REFERENCES

Chromatographic Media and Other Chemicals-- Phosphocellulose P11 was obtained from Whatman, hydroxyapatite from Bio-Rad, HiTrap Desalting, HiTrap heparin, mono Q, and mono S columns from Amersham Biosciences. Pepstatin, leupeptin, and aphidicolin were obtained from Sigma. All other reagents were of analytical grade and purchased from Merck or Fluka.

Buffers-- All stock solutions were filtered through nitrocellulose before use (0.45 µm, Schleicher & Schüll). The following buffers were used: buffer 1 (50 mM Tris-HCl, pH 7.0, 50 mM NaCl, 20% (w/v) sucrose, 1 mM DTT, 2 mM EDTA, 5 µg/ml pepstatin, 1 µg/ml leupeptin, 0.8 mM PMSF); buffer 2 (50 mM Tris-HCl, pH 7.0, 50 mM NaCl, 1% (v/v) Triton X-100, 1 mM DTT, 2 mM EDTA, 5 µg/ml pepstatin, 1 µg/ml leupeptin, 0.8 mM PMSF); buffer 3 (50 mM Tris-HCl, pH 7.0, 1 mM DTT, 2 mM EDTA, 10% (v/v) glycerol, 5 µg/ml pepstatin, 1 µg/ml leupeptin, 0.8 mM PMSF, and different molar concentrations of NaCl), buffer 4 (50 mM Tris-HCl, pH 7.0, 1 mM DTT, 2 mM EDTA, 10% (v/v) glycerol, 5 µg/ml pepstatin, 1 µg/ml leupeptin, 0.8 mM PMSF, and different molar concentrations of potassium phosphate); buffer 5 (50 mM Tris-HCl, pH 7.5, 1 mM DTT, 2 mM EDTA, 10% (v/v) glycerol, 5 µg/ml pepstatin, 1 µg/ml leupeptin, 0.8 mM PMSF, and different molar concentrations of NaCl).

Preparation of Nucleic Acids-- Amersham Biosciences was the supplier of poly(dA) and oligo(dT)12-18. The homopolymer poly(dA) was mixed to the oligomer oligo(dT)12-18 at a 10:1 base ratio in 20 mM Tris, pH 8.0, 20 mM KCl, and 1 mM EDTA heated at 60 °C for 5 min with subsequent slow cooling to room temperature.

Damaged (Apurinic) DNA Template Preparation and Characterization-- To create apurinic sites, the DNA template poly d(A)/oligo d(T) at a 10:1 base ratio was incubated at a final concentration of 0.25 mg/ml at 70 °C in the following buffer: 10 mM sodium citrate, 10 mM NaCl, and 10 mM NaH2PO4, pH 5.2. This treatment specifically hydrolyzes the glycosidic bond between the purine base and the deoxyribose moiety, releasing the base without interrupting the continuity of the sugar-phosphate backbone. The degree of DNA damage was checked at different incubation times by monitoring the loss of DNA synthesis efficiency by pols alpha , beta , and delta . For the preparation of the apurinic poly(dA)/oligo(dT) template, an incubation time of 40 min was selected, corresponding to a loss of 80% DNA synthesis efficiency by pols alpha  and beta  and 73% by pol delta  if compared with the corresponding non-damaged poly(dA)/oligo(dT).

Antibodies-- The mouse monoclonal antibody against rat pol beta  protein was purchased from NeoMarkers (Freemont, CA). The rabbit polyclonal antibody against mouse pol lambda  was a gift from L. Blanco (Madrid, Spain).

DNA Polymerase Assays-- A final volume of 25 µl contained the following components: 50 mM bis-Tris, pH 6.5, 1 mM DTT, 250 µg/ml bovine serum albumin, 6 mM MgCl2, 10 mM KCl, 20 µM [3H]dTTP, 0.5 µg of poly(dA)/oligo(dT)12-18 (10:1 base ratio) or 0.1 µg of depurinated poly(dA)/oligo(dT)12-18 (10: 1 base ratio) and enzyme to be tested. 1 unit of enzyme activity corresponds to the incorporation of 1 nmol of dTTP into acid-precipitable material in 60 min at 37 °C.

Purification of a DNA Polymerase Activity That Preferentially Uses a Damaged DNA Template-- All enzymatic pol tests were performed with poly d(A)/oligo (dT)12-18 or with damaged poly d(A)/oligo (dT)12-18, and isolation steps were performed at or near 0 °C. 70 g of calf thymus were resuspended in 210 ml of buffer 1 and homogenized in a Sorvall Omnimixer. After centrifugation in a GSA rotor at 12,000 rpm for 45 min, the pellet was washed additionally in buffer 1. This pellet (35 g) was resuspended in 140 ml of buffer 2, homogenized, rotated for 2 h, and centrifuged at 12,000 rpm for 45 min. The supernatant (detergent extract) was brought to pH 7.0 to yield fraction I. Fraction I was loaded onto a 60-ml P11 phosphocellulose column, equilibrated previously in buffer 3 with 50 mM NaCl. The column was first washed with 600 ml of buffer 3 (50 mM NaCl), and the proteins were eluted with 500 ml of a linear 50-700 mM gradient of NaCl in buffer 3. The peak fractions containing pol activity on damaged DNA eluted between 220 and 300 mM NaCl and were pooled to yield fraction II. Fraction II was adsorbed to a 6-ml hydroxyapatite column, equilibrated previously in buffer 4. After washing with 10 column volumes of buffer 4 with 20 mM potassium phosphate, a 10-column volume of a linear 20-500 mM potassium phosphate gradient in buffer 4 was developed. On this column, separation of pols that do not synthesize on the damaged template was achieved (see Fig. 1A). The pol activity on the damaged template was eluted between 250 and 350 mM potassium phosphate, pooled, and desalted to yield fraction III. Fraction III was loaded on a 1-ml HiTrap heparin column equilibrated in buffer 3 (50 mM NaCl), the column was washed with 6 ml of buffer 3 (50 mM NaCl), and the pol activity was eluted with a 40-ml linear gradient of 50-1000 mM NaCl in buffer 3. The active fractions were eluted between 550 and 650 mM NaCl, pooled, and desalted to yield fraction IV. Fraction IV was loaded onto a fast protein liquid chromatography mono Q column, equilibrated in buffer 5 (50 mM NaCl), washed with 5 ml of buffer 5 (50 mM NaCl), and eluted with a 15-ml 50-1000 mM NaCl linear gradient in buffer 5. The active fractions were eluted between 380 and 500 mM NaCl, pooled, and desalted to yield fraction V. Fraction V was loaded onto a fast protein liquid chromatography mono S column, equilibrated in buffer 5 (50 mM), and washed with 5 ml of buffer 5 (50 mM NaCl). The pol activity was eluted with a 10-ml 50-500 mM linear gradient in buffer 5 as a homogeneous peak. The active fractions were immediately frozen in small aliquots to -80 °C until further use.

Fidelity Assay-- Bacteriophage M13mp2 and Escherichia coli strains CSH50, NR9099, and MC1061 were as described in Ref. 6. Nonsense mutant M13mp2T90 (point mutation G:T in the position +90 of the lacZ gene) was selected after sequencing analysis of colorless mutants as a mutation hot point in the DNA M13mp forward mutation assay. The sequence of the 26-mer oligonucleotide was: 5'-cga tta agt tgg gta acg cca ggg tt-3'. This oligonucleotide was hybridized in addition to the gap molecules (the 3'-end of the primer being located as three nucleotides from the point substitution T in the nonsense mutant instead of G in M13mp2 DNA at position +90 of lacZ gene) to verify that in every case, the nucleotides were incorporated in the nonsense codon TAA. Forward and reverse mutation assays were done according to Ref. 6. Replication reactions for the forward mutation assay were carried out for 2 h at 37 °C in 10 µl containing: 5 mM MgCl2, 50 mM Tris-HCl, pH 7.2, 1 mM DTT, 100 µg/ml bovine serum albumin, 40 ng of gapped circular M13mp2 DNA, 20 µM each of dATP, dCTP, dGTP, and dTTP, and 0.03 units of either pol lambda  or pol beta . In this case, about 250-300 nucleotides were incorporated per DNA template, although for calculation of the error rate, it was necessary to fill 250 nucleotides of 350 gapped. Replication reactions for the reverse mutation assay were carried out for 10 min by using as a template M13mp2T90 DNA with an additional 26-mer oligonucleotide. All other conditions were identical to the forward mutation assay.

Other Methods-- The following three methods were carried out according to established protocols: SDS-PAGE (7), immunoblotting (8), and in situ polymerase activity gel analysis (9).

    RESULTS AND DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
REFERENCES

Purification of a 67-kDa DNA Polymerase from Calf Thymus Detergent Extract That Preferentially Replicates Damaged DNA-- Calf thymus detergent extract was fractionated using a damaged DNA as the template for measuring DNA polymerase activity (see "Materials and Methods"), and DNA polymerase activity was monitored through different chromatographic steps (Fig. 1A). On the second purification step, a peak eluting between 250 and 350 mM potassium phosphate, which had a similar activity on both the non-damaged and damaged DNA, was separated by the bulk of DNA polymerase activity (Fig. 1B). This activity was then purified through HiTrap Heparin-Sepharose, mono Q and mono S columns. The resulting peak fractions (Fig. 1C) were analyzed on SDS-PAGE and showed a single band of 67 kDa (Fig. 1D).


View larger version (25K):
[in this window]
[in a new window]
 
Fig. 1.   Purification of a 67-kDa DNA polymerase from calf thymus detergent extract that preferentially replicates damaged DNA. A, flow chart of the purification procedure (for details, see "Materials and Methods"). F, fraction. B, chromatographic separation of a pol that is preferentially active on damaged DNA from the classical pols. The second, minor peak (arrow, eluting between 250 and 350 mM potassium phosphate) shows similar pol activity on non-damaged DNA and on damaged DNA. The specific activities were 7.6 units/mg on non-damaged DNA and 5.1 units/mg on damaged DNA. The pooled fractions 12-17 were used for further purification. C, the last chromatography step, the mono S column. The pol activity eluted between 350 and 300 mM NaCl on mono S column as one peak. The pol activity was 2064 units/mg on damaged DNA versus 1040 units/mg on non-damaged DNA (details of chromatographic behavior are described under "Materials and Methods"). D, fractions V and VI analyzed in a 12.5% SDS-polyacrylamide gel electrophoresis and stained with Coomassie Brilliant Blue. Only one band at a position of 67 kDa was identified in fraction VI. MWM, molecular weight markers.

Identification of the 67-kDa DNA Polymerase as DNA Polymerase lambda -- The final mono S fraction (fraction VI) was analyzed by immunoblot for a variety of known pols, such as pols alpha , beta , delta , and epsilon . No bands were observed with antibodies against pols alpha , delta , and epsilon  (data not shown), but a strong signal was discovered for a 67-kDa polypeptide with a monoclonal antibody against human recombinant pol beta  (Fig. 2A), suggesting that we had isolated a beta -like pol. Next, the same mono S fraction was tested with an antibody against pol lambda , and a clear signal was again obtained for this polypeptide (Fig. 2B). All pols of family X have very conserved DNA polymerase domains (2); therefore, the cross-reactivity of pol lambda  with pol beta  antibody was not unexpected. Next, we tested whether this 67-kDa polypeptide was responsible for the polymerase activity. As shown in Fig. 2C, in situ activity gel analysis showed that the polypeptide corresponding to the 67-kDa band was able to incorporate nucleotides into a DNA template. These data strongly suggested that the pol isolated from calf thymus using a damaged DNA as the template is pol lambda . Accordingly, only pol lambda  among family X pols has an expected molecular mass of 64-67 kDa based on the cDNA sequence of human and mouse.


View larger version (40K):
[in this window]
[in a new window]
 
Fig. 2.   Identification of the 67-kDa polypeptide as pol lambda . A, fractions (F) V and VI (see panel A of Fig. 1) immunoblotted after 12.5% SDS-polyacrylamide gel electrophoresis with monoclonal antibodies against pol beta . The pol beta  antibody cross-reacted with a band at position 67 kDa in both fractions. The recombinant pol beta  was used as a positive control. MWM, molecular weight markers. B, immunoblot analysis for pol lambda . Polyclonal antibodies against pol lambda  cross-reacted with a 67-kDa polypeptide in both fractions V and VI. C, activity gel analysis performed to confirm the pol activity in the 67-kDa polypeptide. Fraction VI and pol beta  were tested in a 12% SDS-PAGE activity gel analysis as described under "Materials and Methods."

It has been reported that N-terminal domain of pol lambda  shares similarity with yeast pol IV and that the C-terminal domain shares similarity with mammalian pol beta  (2). Although yeast pol IV shows the properties typical for pol beta , the apparent molecular mass of the polypeptide is larger (68 kDa) (10). Therefore, it is possible that pol lambda , rather than pol beta , is the homolog of yeast pol IV.

Biochemical Properties of DNA Polymerase lambda -- Since the pol activity after the last mono S column was low, an optimization and characterization was performed. These are summarized in Fig. 3. The pH optimum of pol lambda  was 6.5 with 50 mM bis-Tris, Tris-HCl, or 15 mM potassium phosphate buffers. The Mg2+ optimum was 1.5 mM, and for Mn2+, it was 0.5 mM. The Km for the nucleotide substrate (dTTP) was 5.9 µM, and the Vmax was 0.38 pmol/min. The ratio Vmax/Km was 2.57 × 10-3 min-1 × 1 µl-1, which is a lower estimation of kcat/Km. These results are significantly different from those for human recombinant pol lambda , which has low Km (0.5 µM) for the nucleotide substrate and optimal conditions for pol activity at pH 7.5 and 10 mM MgCl2 (11). Pol beta  is resistant to inhibition by aphidicolin (10, 12); therefore, it was interesting to examine the purified calf thymus pol lambda  for this inhibitor. Unexpectedly and in contrast to pol beta , pol lambda  was aphidicolin-sensitive.


View larger version (31K):
[in this window]
[in a new window]
 
Fig. 3.   Biochemical properties of calf thymus DNA polymerase lambda . All pol lambda  assays were performed as described under "Materials and Methods." 100% of activity corresponds to 21 units/ml on damaged DNA. A, dependence of activity on divalent cations. F, fraction. B, dependence of the activity on the pH in different buffer systems. C, sensitivity of polymerase activity to aphidicolin. DNA pol lambda  was inhibited by aphidicolin (big squares). DNA pol beta  was used in the same experiment as a control for aphidicolin resistance (small squares). D, dependence of reaction velocity on dTTP concentration. Curves were fitted to the experimental points by non-linear least squares fitting.

Fidelity of DNA Polymerases lambda  and beta  in a Forward and in a Reverse Mutation Assay-- Pol beta  is the least accurate classical mammalian pol, with an average substitution error rate of about 10-3 (13). Human recombinant pol µ (a member of family X DNA polymerases) is an error-prone pol (14). Replication fidelity of natural pol lambda  has never been measured before. Therefore, we compared the fidelity of calf thymus pol lambda  with human recombinant pol beta . A 6-fold more accurate synthesis was observed for pol lambda  as compared with pol beta  in a forward mutation assay (Table I) when both base substitution and frameshift mutation were determined. We have used 2-h gap filling reactions. Under these conditions, even if neither a 3'right-arrow5' exonuclease nor any other nuclease was identified in pol lambda  fractions, a very minor proofreading activity could influence the overall fidelity due to a long incubation. To exclude this probability and estimate a share of base substitutions from total errors, we used the additional reverse mutation system on M13mp2T90 DNA with only a 10-min synthesis (see "Materials and Methods"). The data from Table II confirmed a 5-fold higher fidelity of pol lambda  as compared with pol beta . Errors can occur during any DNA synthesis reaction in a cell, including the gap filling synthesis required for mismatch repair, BER, or nucleotide excision repair. These repair processes require different amounts of DNA resynthesis, catalyzed by pols having very different error rates. The main repair pol beta  has an average substitution error rate of about 10-3. If this was the error rate in vivo, only BER-associated synthesis of pol beta  would yield about 10 errors per day (15). However, the fidelity of a complete BER complex must be higher than that of the pol alone. It was shown that pol beta  misinsertion might be proofread by an extrinsic exonuclease (16, 17) or subsequently corrected by some forms of DNA mismatch repair. Furthermore, it was shown that an alternative BER pathway can utilize pols delta  and epsilon . Using nuclear extracts from wild-type and beta -pol null mouse fibroblasts, it has been demonstrated that this alternative BER pathway has a repair patch size of about two to six nucleotides (18). We have identified pol lambda  from calf thymus as a pol activity scoring better on damaged versus non-damaged DNA. The facts that pol lambda  can incorporate nucleotides on damaged DNA and has 5- to 6-fold higher fidelity than pol beta  suggest that pol lambda  can contribute substantially to DNA repair. Thus, based on our results, we suggest that pol lambda  could be responsible for this additional long patch BER pathway. It was shown recently that human recombinant pol lambda  performs a limited but significant strand displacement synthesis on gapped DNA substrates, a capacity that would be essential to allow the participation of pol lambda  in long patch BER (5). It was also shown that human recombinant pol lambda  exhibits 5'-deoxyribose phosphate lyase activity and, in coordination with its polymerization activity, efficiently repaired uracil-containing DNA in an in vitro reconstituted BER reaction. Thus, pol lambda  may participate in single-nucleotide BER in mammalian cells. The mRNA for human pol lambda  was highly abundant in testis, although basal levels were detected in all tissues examined (2). Therefore, and in addition to demonstrating its putative role in meiotic recombination, it will be relevant to determine whether pol lambda  could also have a role in homologous recombination (e.g. repair of double-stranded breaks, a process contributing to genetic stability in somatic cells).

                              
View this table:
[in this window]
[in a new window]
 
Table I
Mutation frequencies of DNA polymerases lambda  and beta  by the forward mutation assay

                              
View this table:
[in this window]
[in a new window]
 
Table II
Mutation frequencies of DNA polymerases lambda  and beta  by the reverse mutation assay


    ACKNOWLEDGEMENTS

We thank L. Blanco for polyclonal antibodies against mouse pol lambda  and for critical reading of the manuscript and Graziella Pedrazzi for help in preparing the figures.

    FOOTNOTES

* This work was supported by Grant 3100. 061361. 00 from the Swiss National Science Foundation and by the Kanton of Zürich.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

|| To whom correspondence should be addressed: Institute of Veterinary Biochemistry and Molecular Biology, University of Zürich-Irchel, Winterthurerstrasse 190, CH-8057, Zürich, Switzerland. Tel.: 41-1-635-54-72; Fax: 41-1-635-68-40; E-mail: hubscher@vetbio.unizh.ch.

Published, JBC Papers in Press, March 8, 2002, DOI 10.1074/jbc.M200421200

    ABBREVIATIONS

The abbreviations used are: pol, polymerase; BER, base excision repair; DTT, dithiothreitol; PMSF, phenylmethylsulfonyl fluoride.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
REFERENCES

1. Hübscher, U., Maga, G., and Spadari, S. (2002) Annu. Rev. Biochem. 71, 133-163[CrossRef][Medline] [Order article via Infotrieve]
2. García-Díaz, M., Domínguez, O., López-Fernández, L. A., Laín de Lera, T., Saníger, M. L., Ruiz, J. F., Párraga, M., García-Ortiz, M. J., Kirchhoff, T., del Mazo, J., Bernad, A., and Blanco, L. (2000) J. Mol. Biol. 301, 851-867[CrossRef][Medline] [Order article via Infotrieve]
3. Bork, P., Hofmann, K., Bucher, P., Neuwald, A. F., Altschul, S. F., and Koonin, E. V. (1997) FASEB J. 11, 68-76[Abstract]
4. Zhang, X., Moréra, S., Bates, P. A, Whitehead, P. C., Coffer, A. I., Hainbucher, K., Nash, R. A., Sternberg, M. J. E., Lindahl, T., and Freemont, P. S. (1998) EMBO J. 17, 6404-6411[CrossRef][Medline] [Order article via Infotrieve]
5. García-Díaz, M., Bebenek, K., Kunkel, T. A., and Blanco, L. (2001) J. Biol. Chem. 276, 34659-34663[Abstract/Free Full Text]
6. Kunkel, T. A. (1984) Proc. Natl. Acad. Sci. U. S. A. 81, 1494-1498[Abstract/Free Full Text]
7. Laemmli, U. K. (1970) Nature 227, 680-685[CrossRef][Medline] [Order article via Infotrieve]
8. Towbin, H., Staehelin, T., and Gordon, J. (1979) Proc. Natl. Acad. Sci. U. S. A. 76, 4350-4354[Abstract/Free Full Text]
9. Spanos, A., Sedgwick, S. G., Yarranton, G. T., Hübscher, U., and Banks, G. R. (1981) Nucleic Acids Res. 9, 1825-1839[Abstract/Free Full Text]
10. Shimizu, K., Santocanale, C., Ropp, P. A., Longhese, M. P., Plevani, P., Lucchini, G., and Sugino, A. (1993) J. Biol. Chem. 268, 27148-27153[Abstract/Free Full Text]
11. García-Díaz, M., Bebenek, K., Sabariegos, R., Domínguez, O., Rodriguez, J., Kirchhoff, T., García-Palomero, E., Picher, A. J., Raquel, J., Ruiz, J. F., Kunkel, T. A., and Blanco, L. (2002) J. Biol. Chem. 277, 13184-13191[Abstract/Free Full Text]
12. Waser, J., Hübscher, U., Kuenzle, C. C., and Spadari, S. (1979) Eur. J. Biochem. 97, 361-368[Medline] [Order article via Infotrieve]
13. Osheroff, W. P., Jung, H. K., Beard, W. A., Wilson, S. H., and Kunkel, T. A. (1999) J. Biol. Chem. 274, 3642-3650[Abstract/Free Full Text]
14. Domínguez, O., Ruiz, J. F., Laín de Lera, T., García-Díaz, M., González, M. A., Kirchhoff, T., Martínez-A, C., Bernad, A., and Blanco, L. (2000) EMBO J. 19, 1731-1742[CrossRef][Medline] [Order article via Infotrieve]
15. Kunkel, T. A., and Bebenek, K. (2000) Annu. Rev. Biochem. 69, 497-529[CrossRef][Medline] [Order article via Infotrieve]
16. Höss, M., Robins, P., Naven, T. J. P., Pappin, D. J. C., Sgouros, J., and Lindahl, T. (1999) EMBO J. 18, 3868-3875[CrossRef][Medline] [Order article via Infotrieve]
17. Shevelev, I. V., Belyakova, N. V., Kravetskaya, T. P., and Krutyakov, V. M. (2000) Mutat. Res. 459, 237-242[Medline] [Order article via Infotrieve]
18. Stucki, M., Pascucci, B., Parlanti, E., Fortini, P., Wilson, S. H., Hübscher, U., and Dogliotti, E. (1998) Oncogene 17, 835-843[CrossRef][Medline] [Order article via Infotrieve]


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
K. A. Fiala, W. W. Duym, J. Zhang, and Z. Suo
Up-regulation of the Fidelity of Human DNA Polymerase {lambda} by Its Non-enzymatic Proline-rich Domain
J. Biol. Chem., July 14, 2006; 281(28): 19038 - 19044.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
G. Maga, I. Shevelev, G. Villani, S. Spadari, and U. Hubscher
Human replication protein A can suppress the intrinsic in vitro mutator phenotype of human DNA polymerase {lambda}
Nucleic Acids Res., March 6, 2006; 34(5): 1405 - 1415.
[Abstract] [Full Text] [PDF]


Home page
GENES CELLSHome page
T. Takeuchi, T. Ishidoh, H. Iijima, I. Kuriyama, N. Shimazaki, O. Koiwai, K. Kuramochi, S. Kobayashi, F. Sugawara, K. Sakaguchi, et al.
Structural relationship of curcumin derivatives binding to the BRCT domain of human DNA polymerase {lambda}
Genes Cells, March 1, 2006; 11(3): 223 - 235.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. A. McVoy and D. E. Nixon
Impact of 2-Bromo-5,6-Dichloro-1-{beta}-D-Ribofuranosyl Benzimidazole Riboside and Inhibitors of DNA, RNA, and Protein Synthesis on Human Cytomegalovirus Genome Maturation
J. Virol., September 1, 2005; 79(17): 11115 - 11127.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. K. Braithwaite, R. Prasad, D. D. Shock, E. W. Hou, W. A. Beard, and S. H. Wilson
DNA Polymerase {lambda} Mediates a Back-up Base Excision Repair Activity in Extracts of Mouse Embryonic Fibroblasts
J. Biol. Chem., May 6, 2005; 280(18): 18469 - 18475.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
K. Hashimoto, Y. Tominaga, Y. Nakabeppu, and M. Moriya
Futile short-patch DNA base excision repair of adenine:8-oxoguanine mispair
Nucleic Acids Res., November 5, 2004; 32(19): 5928 - 5934.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
I. Shevelev, G. Blanca, G. Villani, K. Ramadan, S. Spadari, U. Hubscher, and G. Maga
Mutagenesis of human DNA polymerase {lambda}: essential roles of Tyr505 and Phe506 for both DNA polymerase and terminal transferase activities
Nucleic Acids Res., December 1, 2003; 31(23): 6916 - 6925.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Maga, G. Villani, K. Ramadan, I. Shevelev, N. T. Le Gac, L. Blanco, G. Blanca, S. Spadari, and U. Hubscher
Human DNA Polymerase lambda Functionally and Physically Interacts with Proliferating Cell Nuclear Antigen in Normal and Translesion DNA Synthesis
J. Biol. Chem., December 6, 2002; 277(50): 48434 - 48440.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/21/18454    most recent
M200421200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ramadan, K.
Right arrow Articles by Hübscher, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ramadan, K.
Right arrow Articles by Hübscher, U.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.